OMER FY 2013 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$826M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-73.4% YoY

Gross Profit

-$17M-1045.4% margin

Operating Income

-$51M-3157.3% margin

Net Income

-$40M-2487.3% margin

EPS (Diluted)

$-1.39

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$17M

Total Liabilities

$35M

Stockholders' Equity

-$18M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$6M	-73.4%
Gross Profit	-$17M	$6M	-378.6%
Operating Income	-$51M	-$37M	-37.0%
Net Income	-$40M	-$38M	-3.5%